Biotech ETFs In Focus On String Of Q3 Earnings Beat
November 01, 2018 at 19:57 PM EDT
Though the biotech sector is down in October, it shows promise for the long-term due to a wave of mergers & acquisitions and a positive regulatory backdrop.